Slideshow
Author(s):
CMEs offered by the American Academy of Neurology, Cleveland Clinic, Mayo Clinic, and the American Medical Association.
Phase 3 ENSURE Program of Vidofludimus Calcium Continues Following Positive Futility Analysis
Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy
Revised McDonald Diagnostic Criteria Signals New Era in Multiple Sclerosis Treatment
Episode 125: Understanding Major Changes to New McDonald Criteria for Multiple Sclerosis
Details Behind the Phase 3 MyClad Study of Cladribine in Myasthenia Gravis
Beyond Diagnosis: New Data Show Early Nerve Conduction Studies Predict Treatment Outcomes in CIDP